Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease

By rosaguerrero • June 26, 2022

Koury MJ, Agarwal R, Chertow GM, Eckardt KU, Fishbane S, Ganz T, Haase VH, Hanudel MR, Parfrey PS, Pergola PE, Roy-Chaudhury P, Tumlin JA, Anders R, Farag YMK, Luo W, Minga T, Solinsky C, Vargo DL, Winkelmayer WC. Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. Am J Hematol. 2022 Jun 25. doi: 10.1002/ajh.26644. Epub ahead of print. PMID: 35751858.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Related Posts

The Cardiovascular Care of the Pediatric Athlete

Dean PN, Brothers JA, Burns K, Edelson JB, Etheridge S, Phelan DM, Shafer K, Snyder C, Molossi S, Danielian A, Friedman EM, Hsu J, Husaini[...]

A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study

Rosovsky RP, Konstantinides SV, Moriarty JM, Dohad SY, Weinberg I, Parikh SA, Channick R, Lookstein RA. A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone[...]

Reply to Currow et al. and to Akgün

Heinzerling A, Harrison R, Flattery J, Fazio JC, Gandhi S, Cummings KJ. Reply to Currow et al.and to Akgün. Am J Respir Crit Care Med. 2025[...]